about
Met signaling in cardiomyocytes is required for normal cardiac function in adult miceRecurrent syncope after left atrial appendage occlusion.Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome.Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease.What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes.Pharmacokinetic evaluation of argatroban for the treatment of acute coronary syndrome.Association between -T786C NOS3 polymorphism and resistant hypertension: a prospective cohort studyLeft ventricular end-diastolic pressure as an independent predictor of outcome during balloon aortic valvuloplastyHeterozygous disruption of activin receptor-like kinase 1 is associated with increased arterial pressure in mice.Pharmacological and cellular therapies to prevent restenosis after percutaneous transluminal angioplasty and stenting.Left atrial appendage exclusion: state-of-the-art.Transcatheter reduction of paravalvular leaks: a systematic review and meta-analysis.Percutaneous Closure of Paravalvular Leaks: A Systematic Review.Patients with intracranial bleeding and atrial fibrillation treated with left atrial appendage occlusion: Results from the Amplatzer Cardiac Plug registry.Transcatheter closure of paravalvular leaks: state of the art.Long-term experience and outcomes with transcatheter closure of patent foramen ovale.Brain natriuretic peptide levels variation after left atrial appendage occlusion.TAVI through the left subclavian artery with a LIMA graft.[Infective endarteritis in patent ductus arteriosus and septic pulmonary embolism].The echo score revisited: Impact of incorporating commissural morphology and leaflet displacement to the prediction of outcome for patients undergoing percutaneous mitral valvuloplasty.The Ibero-American transcatheter aortic valve implantation registry with the CoreValve prosthesis. Early and long-term results.Percutaneous retrograde closure of mitral paravalvular leak in patients with mechanical aortic valve prostheses.Significance of the learning curve in left atrial appendage occlusion with two different devices.Device Closure of a Ventricular Septal Rupture in a Patient on ECMO.Percutaneous left atrial appendage occlusion in patients with atrial fibrillation and left appendage thrombus: feasibility, safety and clinical efficacy.Left Atrial Appendage Occlusion in the Presence of Thrombus With a LAmbre Device.Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.Computed Tomographic and Fluoroscopic Image Fusion for Pulmonary Vein Stenosis Stenting.Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure With the Amplatzer Cardiac Plug.Cardiovascular Structural Interventions - Echo/Computed Tomography-Fluoroscopy Fusion Imaging Atlas.Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement.Percutaneous Left Atrial Appendage Occlusion: Multimodality Imaging Step-by-step.Reply to the Letter to the Editor: "A peripheral comment".Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach.Percutaneous closure of iatrogenic femoral arteriovenous fistula using a covered coronary stent.Percutaneous Closure of Left Atrial Appendage With Complex Anatomy Using a LAmbre Device.Outcomes and predictors of success and complications for paravalvular leak closure: an analysis of the SpanisH real-wOrld paravalvular LEaks closure (HOLE) registry.Paravalvular Leak Closure After Transcatheter Aortic Valve Implantation Simultaneously Using Amplatzer™ Vascular Plug III and IV Devices.First Magnetic Resonance Managed by a Cardiology Department in the Spanish Public Healthcare System. Experience and Difficulties of an Innovative Model.
P50
Q28297755-CED3DA4F-B93A-4AF0-A3B0-E7B4F775D924Q33164539-0D2AEDEE-4D4D-4EE3-A438-A491BE43E0DBQ33375893-09A0B207-67FD-4394-A41B-71983D882355Q33379961-394F0D6D-3DCE-4701-97B4-23BCDB2FA6FDQ33380193-C10DE9B8-259C-43F1-9CA9-DD50709567DEQ33383263-4EFEC554-5A9A-4050-AADE-249A2F6CF2EAQ33403263-DAFC4107-B47B-4759-9EC4-D912A8E0AAABQ33489898-64A7A347-1319-46B6-BA59-091BA178BB08Q34302820-ADCB7317-9E86-4CC1-BE7B-66A275ACE7CCQ36245158-0A35AE81-7A37-4BC4-A674-B86DF77C5988Q37160726-92FAFE22-BBBC-4427-AD90-E9BBE42975CBQ37678317-B8E7E340-882B-4E3B-A6F0-3C68DDC55FA2Q38368904-F4DF194E-BD82-4984-8BB3-96645CB82CFAQ38848795-D2BDDC7A-45AC-4733-A9C6-934C9BDCC1BAQ38953320-045308CB-FC0B-4763-80EC-01A6D341A2AFQ39017707-6643C58E-6226-4BF4-861E-FB3B1FA8F31BQ39310239-E64596F5-882C-44D3-A23C-CFEAA17D93B4Q41702126-24B3647E-2E74-41F2-ADA4-1E44A9CA83F8Q43719903-54856C61-8C2E-4F2D-BEA2-FE818BE3D37BQ44157894-15D5A777-77CF-4187-98F6-1A20C81F9F32Q44556839-9266A7A0-8CA4-459A-BBCB-FE5FFE03D688Q45804040-26E17B8F-9F8A-4664-B4F5-C67DAECBA3C5Q46012719-845F7279-5743-4030-A7E8-171B1DB29F44Q46668382-291962EA-781D-40A4-AC20-36EEC61A97C1Q47271823-386773E7-AE36-4D42-897E-EB16E8D6E05FQ47396474-0CF9C0D3-6651-4D22-A65B-F06E6F90ED7CQ47424011-17507AA4-DD9C-4895-A522-35D95441476BQ47659787-B920C396-776C-404A-80DC-E33EDFBB8D91Q47751196-96A495A4-CE9B-4CF3-8665-41FCE5859D98Q47849612-61673C16-445F-4D70-A82E-99EDCFB93ADBQ49788053-F8964834-FC96-41C6-96AD-B05F03BA6E56Q50056478-AD6D0682-0D7D-4B50-9886-A142908D8484Q50064412-661306E1-C2E6-4375-B1E3-43170AA2893AQ50068486-0060AECF-20C8-4AC1-8DC9-C1C0FB9E3A4BQ50859080-6BA53D77-5999-4321-AE62-0A5CC835D8FCQ50868318-ADB2FDF9-97B2-4595-A3D3-987490DDFC6DQ50992718-7D786EAC-8709-451D-8EC9-F9564952BBB2Q51079776-6691A11E-B333-4B22-86F7-B1B8F2E92EEEQ51691892-1DBDE8E2-C633-4C64-95E8-A9D8526610B2Q51730716-B8F3EC4C-FBA3-4537-9C54-015F78318A5B
P50
description
researcher ORCID ID = 0000-0001-9742-6072
@en
wetenschapper
@nl
name
Ignacio Cruz-Gonzalez
@ast
Ignacio Cruz-Gonzalez
@en
Ignacio Cruz-Gonzalez
@es
Ignacio Cruz-Gonzalez
@nl
type
label
Ignacio Cruz-Gonzalez
@ast
Ignacio Cruz-Gonzalez
@en
Ignacio Cruz-Gonzalez
@es
Ignacio Cruz-Gonzalez
@nl
prefLabel
Ignacio Cruz-Gonzalez
@ast
Ignacio Cruz-Gonzalez
@en
Ignacio Cruz-Gonzalez
@es
Ignacio Cruz-Gonzalez
@nl
P106
P1153
16686465300
P21
P31
P496
0000-0001-9742-6072